Evofem Biosciences (EVFM) Receivables (2019 - 2026)
Evofem Biosciences (EVFM) recorded Receivables of $2.5 million in Q2 2026, down 49.4% from $4.93 million a year earlier but up 345.9% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Evofem Biosciences reported Receivables of $12.48 million, up 26.9% from FY2024.
- Annual Receivables has increased for three straight years, with a five-year compound annual growth rate of 55.6% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $9.83 million in FY2024 (+71.3%), $5.74 million in FY2023 (+409.6%), $1.13 million in FY2022 (-82.5%) and $6.45 million in FY2021 (+371.8%).
- Quarterly Receivables has ranged from $560,000 in Q1 2026 to $12.76 million in Q3 2022 over the past five years.
- On a year-over-year basis, Receivables rose in three of the last eight quarters, with an average decline of 12.7%.
- Peak year-over-year performance for Receivables in the last five years was growth of 409.6% in Q4 2023, against a decline of 82.5% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $560,000 (Q1 2026), $12.48 million (Q4 2025) and $4.44 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | 2.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.50 Mn |
| Mar 31, 2026 | 560,000.00 |
| Dec 31, 2025 | 12.48 Mn |
| Sep 30, 2025 | 4.44 Mn |
| Jun 30, 2025 | 4.93 Mn |
| Mar 31, 2025 | 1.15 Mn |
| Dec 31, 2024 | 9.83 Mn |
| Sep 30, 2024 | 5.39 Mn |
| Jun 30, 2024 | 4.62 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 5.74 Mn |
| Sep 30, 2023 | 6.32 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 7.40 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 12.76 Mn |
| Jun 30, 2022 | 7.30 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 6.45 Mn |
| Sep 30, 2021 | 4.03 Mn |
API Access
Evofem Biosciences Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();